Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1012709 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Asgeir Kobro-Flatmoen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Kavli Institute for Systems Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Neuronal, Serine Endopeptidases, Extracellular Matrix Proteins, Nerve Tissue Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Liaison Committee for Education, Research and Innovation in Central Norway, Jebsen Foundation, The Kavli Foundation.
Themen: Demenz
Abstract (Originalsprache)
Numerous studies of the human brain supported by experimental results from rodent and cell models point to a central role for intracellular amyloid beta (Aβ) in the onset of Alzheimer’s disease (AD). In a rat model used to study AD, it was recently shown that in layer II neurons of the anteriolateral entorhinal cortex expressing high levels of the glycoprotein reelin (Re + alECLII neurons), reelin and Aβ engage in a direct protein–protein interaction. If reelin functions as a sink for intracellular Aβ and if the binding to reelin makes Aβ physiologically inert, it implies that reelin can prevent the neuron from being exposed to the harmful effects typically associated with increased levels of oligomeric Aβ. Considering that reelin expression is extraordinarily high in Re + alECLII neurons compared to most other cortical neurons, such a protective role appears to be very difficult to reconcile with the fact that this subset of ECLII neurons is clearly a major cradle for the onset of AD. Here, we show that this conundrum can be resolved if Re + alECLII neurons have a higher maximum production capacity of Aβ than neurons expressing low levels of reelin, and we provide a rationale for why this difference has evolved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kavli Institute for Systems Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
- K. G. Jebsen Centre for Alzheimer's Disease, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
- Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
ORCID-Profile: Asgeir Kobro-Flatmoen
Förderung
- The Liaison Committee for Education, Research and Innovation in Central Norway
- Jebsen Foundation
- The Kavli Foundation
- The K. G. Jebsen Foundation
- Civitan Norway
Zitieren
APA
Kobro-Flatmoen, A., & Omholt, S. W. (2025). Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012709
Vancouver
Kobro-Flatmoen A, Omholt SW. Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1012709
BibTeX
@article{KobroFlatmoen2025,
author = {Kobro-Flatmoen, Asgeir and Omholt, Stig W},
title = {Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1012709}
}
EUVIMED